Hogan Lovells logo
  • Our people
  • What we do
    Sectors Practices Legal Tech
    • Our sector offering
    • Aerospace and Defense
    • Automotive and Mobility
    • Consumer
    • Education
    • Energy
    • Financial Institutions
    • Insurance
    • Life Sciences and Health Care
    • Manufacturing and Industrials
    • Private Capital
    • Real Estate
    • Sports, Media and Entertainment
    • Technology
    • Transportation and Logistics
    • Corporate & Finance
    • Disputes
    • Global Regulatory
    • Intellectual Property
  • Case studies
  • Our thinking
    • All Our thinking
    • Comparative guides
    • Digital Client Solutions
    • Events and webinars
    • Podcasts
    Insights and Analysis image_2

    AI-washing – when AI hype becomes a litigation risk

  • ESG
  • Careers
Search Search
close
Search Search Search
lang-sel-icon English
  • Deutsch
  • English
  • Español
  • Français
  • 日本語
  • 中文
False
people-new
Mobile area
  • About us
    • Our difference
    • Global management team
  • Where we are
    • Our locations
    • Law Firm Network
  • Media center
    • Media contacts
    • Press releases
    • Awards & rankings
  • Responsible Business
  • HL Inclusion
  • Alumni
LinkedIn
Youtube
twitter
Wechat
Hogan Lovells Our thinking banner ""

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.
Back to Our thinking
Topics
Countries
Language
Date
Clear
"{0}"

    News

    FDA extends comment period for real-time clinical trials pilot, AI use in studies (updated)
    01 June 2026

    Insights and Analysis

    FDA one-day inspections pilot: What to expect and how to prepare
    27 May 2026

    News

    Drug repurposing: FDA seeks comments on how to address unmet medical needs
    26 May 2026

    News

    FDA Issues Two New Prevention-Focused Food Safety Resources
    20 May 2026

    News

    FDA announces one-day inspection pilot
    14 May 2026

    News

    FDA AI tool Elsa 4.0 and HALO unveiled
    08 May 2026

    News

    House committee report signals limits on foreign clinical data
    06 May 2026

    Insights and Analysis

    Trump promotes psychedelic drug availability but legal issues remain
    24 April 2026

    News

    Polling, history point to Democratic takeover of House and possibly Senate – clients should prepare now
    22 April 2026

    Insights and Analysis

    China tightens criminal enforcement of bribery: What it means for health care companies
    17 April 2026

    News

    FDA signals heightened enforcement focus on ClinicalTrials.gov compliance
    17 April 2026

    Insights and Analysis

    Playing the odds – or the information?: The CFTC signals a crackdown on prediction market insider trading, and how companies should respond
    07 April 2026

    No results found

    Load more

    "" ""
    Digital Client Solutions
    Empowering you to lead change through our digital solutions.
    Learn more
    Hogan Lovells logo
    Contact us
    Quick Links
    • About us
    • Where we are
    • Media center
    • Responsible Business
    • HL Inclusion
    • Alumni
    • Contact us
    • Cookies
    • Disclaimer
    • Fraudulent and Scam Emails
    • Legal notices
    • Modern Slavery Statement
    • Our thinking terms of use
    • Privacy
    • RSS
    Connect with us
    LinkedIn
    Youtube
    Twitter
    Wechat

    © 2026 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.

    Subscribe to Our thinking
    Connect with us
    LinkedIn
    Youtube
    Twitter
    Wechat